Mr. Speaker, the CIHR, Canadian Institutes of Health Research, really has been driving this agenda over the last few weeks. It has come out with its own guidelines and in effect has pre-empted this piece of legislation. We are wondering whether or not that was something that was set up by the minister. Maybe it is not really that important, but it is something we question.
The president of the CIHR has suggested that it is not driving for the safe alternative, which is the adult stem cell. The member elaborated on that and I could not agree more that it is an avenue of no ethical concern and tremendous potential which Canadians would be proud to endorse. On the other side is the embryonic stem cell research which is full of hope, but all it is is hope and very weak research.
The CIHR is pushing the envelope toward embryonic stem cell research. Last year the president of the CIHR, Dr. Bernstein, said in committee that the number one issue in the legislation is the regulatory body and the trust it garners from Canadians. Does the way the legislation is written reflect trust for Canadians?